Research ArticleSupplement

The Role of Total-Body PET in Drug Development and Evaluation: Status and Outlook

Xiangxi Meng, Xiangxing Kong, Lei Xia, Runze Wu, Hua Zhu and Zhi Yang
Journal of Nuclear Medicine May 2024, 65 (Supplement 1) 46S-53S; DOI: https://doi.org/10.2967/jnumed.123.266978

Article Information

vol. 65 no. Supplement 1 46S-53S
DOI 
https://doi.org/10.2967/jnumed.123.266978
PubMed 
38719239
Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication October 31, 2023
  • Revision received January 23, 2024
  • Published online May 6, 2024.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Xiangxi Meng1,
  2. Xiangxing Kong1,
  3. Lei Xia1,
  4. Runze Wu2,
  5. Hua Zhu1 and
  6. Zhi Yang1
  1. 1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), National Medical Products Association, Key Laboratory for Research and Evaluation of Radiopharmaceuticals, National Medical Products Association, Department of Nuclear Medicine, Peking University Cancer Hospital & Institute, Beijing, China; and
  2. 2Beijing United Imaging Research Institute of Intelligent Imaging, Beijing, China
  1. For correspondence or reprints, contact Zhi Yang (pekyz{at}163.com).
View Full Text

Statistics from Altmetric.com

Cited By...

Article usage

Article usage: May 2024 to April 2025

AbstractFullPdf
May 20241206141100
Jun 20246342717
Jul 202429915739
Aug 202413921447
Sep 202412316443
Oct 20249321039
Nov 20249919446
Dec 202410719786
Jan 20258123561
Feb 20257523667
Mar 20256520062
Apr 20256429268
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords